303 related articles for article (PubMed ID: 4701464)
1. A field trial of combined measles-mumps-rubella vaccine. Satisfactory immunization with 188 children in Chile.
Borgoño JM; Greiber R; Solari G; Concha F; Carrillo B; Hilleman MR
Clin Pediatr (Phila); 1973 Mar; 12(3):170-2. PubMed ID: 4701464
[No Abstract] [Full Text] [Related]
2. [Experience with preventive measles, mumps and rubella vaccination in unified Germany].
Gerike E; Tischer A
Gesundheitswesen; 1993 Jan; 55(1):38-9. PubMed ID: 8435543
[TBL] [Abstract][Full Text] [Related]
3. [Conjugated vaccine against measles, rubella and mumps].
Vopr Virusol; 1989; 34(1):117-9. PubMed ID: 2728403
[No Abstract] [Full Text] [Related]
4. Administration of measles-mumps-rubella vaccination with other childhood schedule vaccines.
Heath TC; Burgess MA; O'Brien ED
Commun Dis Intell; 1998 Aug; 22(8):159. PubMed ID: 9735551
[No Abstract] [Full Text] [Related]
5. [Prevalence of antibodies and vaccination against measles, mumps and rubella in Polish population].
Janaszek-Seydlitz W; Bucholc B; Wysokińska T; Górska P; Gniadek G
Przegl Epidemiol; 2003; 57(2):281-8. PubMed ID: 12910596
[TBL] [Abstract][Full Text] [Related]
6. [Field trial with a new human diploid cell vaccine (HDCV) against measles, mumps and rubella].
Just M; Berger R; Glück R; Wegmann A
Schweiz Med Wochenschr; 1985 Nov; 115(48):1727-30. PubMed ID: 4081704
[TBL] [Abstract][Full Text] [Related]
7. [Immunity to measles, mumps and rubella in children vaccinated with triple viral vaccine].
Pisón Garcés FJ; Galbe Sánchez-Ventura J; Arcauz Eguren P; Aguirre y Dabán C; Mengual Gil J; Larrad Mur L
Aten Primaria; 1995 Mar; 15(4):235-7. PubMed ID: 7703334
[TBL] [Abstract][Full Text] [Related]
8. [Morbidity, vaccine coverage and immunity against measles, mumps and rubella in a Gallician population from 2 to 5 years old].
Vázquez Fernández E; López Rois F; Vázquez Carrete JA; Gómez Tato B; Alvarez Ares M
An Esp Pediatr; 1987 Jul; 27(1):27-31. PubMed ID: 3662251
[TBL] [Abstract][Full Text] [Related]
9. [Measles, mumps and rubella: vaccination rate and seroprevalence in 8th grade students of 8 different sites in Switzerland 1995/96].
Stohrer-Draxl P; Amstad H; Grize L; Gassner M; Takken-Sahli K; Bourquin C; Braun-Fahrländer C
Praxis (Bern 1994); 1999 Jun; 88(24):1069-77. PubMed ID: 10420798
[TBL] [Abstract][Full Text] [Related]
10. Response to measles-mumps-rubella vaccine in children on dialysis.
Schulman SL; Deforest A; Kaiser BA; Polinsky MS; Baluarte HJ
Pediatr Nephrol; 1992 Mar; 6(2):187-9. PubMed ID: 1571219
[TBL] [Abstract][Full Text] [Related]
11. Combined live measles, mumps, and rubella virus vaccines.
Buynak EB; Weibel RE; Whitman JE; Stokes J; Hilleman MR
JAMA; 1969 Mar; 207(12):2259-62. PubMed ID: 5818433
[No Abstract] [Full Text] [Related]
12. The measles-mumps-rubella vaccination program in Finland.
Redd SC; Wharton M; Hadler SC; Orenstein WA
N Engl J Med; 1995 Apr; 332(16):1102-3. PubMed ID: 7898540
[No Abstract] [Full Text] [Related]
13. Decreased measles antibody response after measles-mumps-rubella vaccine in infants with colds.
Krober MS; Stracener CE; Bass JW
JAMA; 1991 Apr; 265(16):2095-6. PubMed ID: 2013930
[TBL] [Abstract][Full Text] [Related]
14. [1st results with a combined live vaccine against measles, mumps, and rubella].
Stehr K; Epp C; Spiess H
Monatsschr Kinderheilkd (1902); 1975 May; 123(5):410-2. PubMed ID: 1219453
[No Abstract] [Full Text] [Related]
15. [Vaccination rate for triple measles-rubella-mumps vaccine in Empoli Val d'Elsa area health district U.S.L. 11, Tuscany Region].
Salvadori P
Ann Ig; 1998; 10(1):19-24. PubMed ID: 9616974
[No Abstract] [Full Text] [Related]
16. Mumps vaccination.
Hilleman MR
Mod Trends Med Virol; 1970; 2(0):241-61. PubMed ID: 5527958
[No Abstract] [Full Text] [Related]
17. Measles, mumps, and rubella vaccine: time for a two stage policy.
Sloan DS
BMJ; 1992 Apr; 304(6831):916. PubMed ID: 1392776
[No Abstract] [Full Text] [Related]
18. A field with a liver measles-mumps-rubella vaccine.
Walters VW; Miller SA; Jackson JE; Kenny MT
Clin Pediatr (Phila); 1975 Oct; 14(10):928-33. PubMed ID: 1100294
[TBL] [Abstract][Full Text] [Related]
19. [Certain problems with limits of immunity against measles, mumps and rubella].
Magdzik W
Przegl Epidemiol; 1993; 47(1-2):47-53. PubMed ID: 8351387
[TBL] [Abstract][Full Text] [Related]
20. The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program.
Peltola H; Heinonen OP; Valle M; Paunio M; Virtanen M; Karanko V; Cantell K
N Engl J Med; 1994 Nov; 331(21):1397-402. PubMed ID: 7969278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]